Opioid Use Disorder Treatment
Opioid Use Disorder Treatment is a research topic within Public Health, Environmental and Occupational Health. Science Explorer counts 26k research works in it since 1950. 24.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the opioid epidemic in the United States, covering topics such as opioid prescribing guidelines, chronic pain management, opioid overdose, addiction treatment, prescription opioids, mortality risk, substance use disorders, abuse and dependence, medication-assisted therapy, and the public health crisis associated with opioid misuse.
- Opioid Prescribing
- Chronic Pain Management
- Opioid Overdose
- Addiction Treatment
- Prescription Opioids
- Mortality Risk
- Substance Use Disorders
- Abuse and Dependence
- Medication-Assisted Therapy
- Public Health Crisis
- Research works
- 26k fractional, since 1950
- In the world top 10%
- 6.3k per year above
- Top-10% rate
- 24.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +98% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Opioid Use Disorder Treatment research?
By volume, the United States and Canada publish the most (4.5k and 527 works in 2022–2025).
By volume, 2022–2025
- 1 United States 4.5k works
- 2 Canada 527 works
- 3 Australia 293 works
- 4 United Kingdom 290 works
- 5 India 113 works
- 6 France 113 works
- 7 China 95 works
- 8 Spain 92 works
- 9 Germany 77 works
- 10 Norway 71 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Opioid Use Disorder Treatment research?
By volume in 2022–2025, Johns Hopkins University publishes the most Opioid Use Disorder Treatment research, followed by University of North Carolina at Chapel Hill and Yale University.
By volume, 2022–2025
- 1 Johns Hopkins University United States 94 works
- 2 University of North Carolina at Chapel Hill United States 83 works
- 3 Yale University United States 70 works
- 4 Harvard University United States 57 works
- 5 University of Kentucky United States 54 works
- 6 New York University United States 52 works
- 7 University of Washington United States 51 works
- 8 University of Michigan United States 50 works
- 9 University of Pennsylvania United States 42 works
- 10 University of California, San Francisco United States 41 works
Who are the leading researchers in Opioid Use Disorder Treatment?
The most-cited researchers publishing on Opioid Use Disorder Treatment include Roger Chou, Dan J. Stein and Louisa Degenhardt.
- 1 Roger Chou 14k citations
- 2 Dan J. Stein 7.7k citations
- 3 Louisa Degenhardt 5.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Opioid Use Disorder Treatment research done?
The largest centres of Opioid Use Disorder Treatment research in 2022–2025 are New York (United States), Boston (United States), Baltimore (United States) and Philadelphia (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Santa Monica, Lexington and Providence.
Largest cities, 2022–2025
- 1 New York United States 226 works
- 2 Boston United States 201 works
- 3 Baltimore United States 182 works
- 4 Philadelphia United States 132 works
- 5 Toronto Canada 118 works
- 6 Vancouver Canada 98 works
- 7 Washington D.C. United States 95 works
- 8 Chapel Hill United States 87 works
- 9 New Haven United States 87 works
- 10 Seattle United States 85 works
Where it is the local speciality
- Santa MonicaUS · 25.8 works24×
- LexingtonUS · 56.7 works17×
- ProvidenceUS · 70.8 works17×
Location quotient: how much more of its research is in Opioid Use Disorder Treatment than the world average.
Where is the best place to study Opioid Use Disorder Treatment?
Among universities, judged by research, Boston University, Johns Hopkins University and New York University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Boston University United States | 74.1 | 32.8% | 11.9× | 39 | +178.2% |
| 2 | Johns Hopkins University United States | 71.4 | 24.2% | 13.1× | 94 | +121.1% |
| 3 | New York University United States | 71.2 | 29.7% | 9.8× | 52 | +145.3% |
| 4 | Brown University United States | 69.4 | 25.1% | 15.2× | 40 | +202.6% |
| 5 | Harvard University United States | 66.4 | 25.2% | 6.7× | 57 | +185.4% |
| 6 | University of California, San Francisco United States | 64.9 | 25.8% | 9.8× | 41 | +123.4% |
| 7 | Yale University United States | 63.7 | 21.7% | 10.4× | 70 | +77.6% |
| 8 | The University of Texas Health Science Center at Houston United States | 61.9 | 24.7% | 9.8× | 19 | +284.6% |
| 9 | Oregon Health & Science University United States | 61.5 | 29.2% | 14.7× | 30 | +92.4% |
| 10 | University of Victoria Canada | 61.4 | 46.3% | 6.8× | 10 | +112.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Opioid Use Disorder Treatment research growing?
Output in 2018–2022 was 98% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Opioid Use Disorder Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.